arrow
C

Carmine Ostacolo

University of Salerno
H指数:29
被引数:2,142

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular Basis for Activation to Inhibition Switching in Kv7.2 Channel Modulators

Kv7.2通道调节剂中从激活到抑制的转换的分子机制

2026-08-280
OAAI
Metabolic Reprogramming Associated with Ferroptosis Protection by an Indole-Based Antioxidant in Aβ(25–35)-Treated SH-SY5Y Cells

吲哚基抗氧化剂介导的 ferroptosis 保护作用与 Aβ(25–35) 处理的 SH-SY5Y 细胞中代谢重编程的关系

2026-07-280
OA
Targeting Cathepsins in Neurodegeneration: Biochemical Advances

靶向神经退行性疾病中的组织蛋白酶:生物化学进展

2026-03-040
OAAI
An adamantylureido-benzylamide aniline as FLAP/sEH dual inhibitor: rational design, in vitro and in vivo lipidomic profiling

adamantylureido-苄酰胺苯胺作为FLAP/sEH双抑制剂:理性设计、体外及体内脂质组学分析

2025-11-030
PRE
Untargeted Diversity-Oriented Synthesis for the Discovery of New Antitumor Agents: An Integrated Approach of Inverse Virtual Screening; Bioinformatics; and Omics for Target Deconvolution

靶向多样性导向合成用于抗癌新药发现:一种整合反向虚拟筛选、生物信息学和组学技术进行靶点解卷积的综合方法

2025-07-240
OA
The fast-dissociating D2 antagonist antipsychotic JNJ-37822681 is a neuronal Kv7 channel opener: Potential repurposing for epilepsy treatment

快速解离的D2拮抗剂型抗精神病药JNJ-37822681是一种神经元Kv7通道开放剂:用于癫痫治疗的潜在再利用

2025-07-230
OAAI
Novel Para-Phenylenediamine-Based Derivatives as Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors: An In Vitro Preliminary Characterization

新型对苯二胺基衍生物作为受体酪氨酸激酶样孤寡受体1(ROR1)抑制剂:体外初步表征

2025-06-010
PREAI
Furazanopyrazine-based novel promising anticancer agents interfering with the eicosanoid biosynthesis pathways by dual mPGES-1 and sEH inhibition
2025-05-010
OAAI
Neuroprotective Potential of Indole-Based Compounds: A Biochemical Study on Antioxidant Properties and Amyloid Disaggregation in Neuroblastoma Cells
2024-12-230
OAAI
A Comprehensive In Vitro Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors
2024-07-221
PRE
KCNT1 Channel Blockers: A Medicinal Chemistry Perspective

KCNT1通道阻滞剂: 药物化学观点

2024-06-202
OAAI
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel
2024-05-235
OAAI
Novel pyrrole based CB2 agonists: New insights on CB2 receptor role in regulating neurotransmitters' tone
2024-04-014
OAAI
Peptidomimetics as potent dual SARS-CoV-2 cathepsin-L and main protease inhibitors: In silico design, synthesis and pharmacological characterization
2024-02-016
OAAI
A Combination of Polymethoxyflavones from Citrus sinensis and Prenylflavonoids from Humulus lupulus Counteracts IL-1β-Induced Differentiated Caco-2 Cells Dysfunction via a Modulation of NF-?B/Nrf2 Activation
2023-08-166
OAAI
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis
2023-06-198
OAAI
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: In Vitro and In Vivo Anti-Inflammatory Characterization
2022-11-0117
OAAI